NovaBay Pharmaceuticals, Inc. NBY
Set alert
1.47 USD 0.00 0.00%
As of May 22, 12:37 PM ET
1.47 Day range 1.47
0.36 52-week range 9.10
- YTD
- -94.79%
- 1 year
- -47.32%
- Open
- 1.47
- Prev close
- 1.47
- Mkt cap
- 2.52M
- Vol
- 86.83K
- Avg vol
- 476.87K
- EPS
- -74.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.47
- High
- 1.47
- Forward P/E
- -0.63
- Beta
- 0.00
- Short ratio
- 0.07
- Inst. own
- 2.58%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.6314
- 200-d avg
- 1.85
- 1y target
- 3.73
2Y chart
Events in this range
- May 31, 2024Split: 1 for 35
- Nov 11, 2024Rating: Ascendiant Capital · Buy → Buy
- Sep 30, 2025Dividend: 0.8
- Feb 23, 2026Split: 1 for 5
Signals (72)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| RSI: Overbought | Dec 9, 2025 | 10 months ago |
| SMA: Bullish | Dec 5, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bullish | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 21, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 2, 2025 | 1 year ago |
| SMA: Bearish | Sep 30, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| RSI: Overbought | Aug 27, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| RSI: Overbought | Aug 20, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 18, 2025 | 1 year ago |
| SMA: Bullish | Jun 17, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| SMA: Bullish | Jun 12, 2025 | 1 year ago |
| RSI: Overbought | Jun 12, 2025 | 1 year ago |
| SMA: Bullish | Jun 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 4, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 13, 2025 | 1 year ago |
| MACD: Sell Signal | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| SMA: Bullish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| RSI: Overbought | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| SMA: Bearish | Nov 25, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| MACD: Buy Signal | Oct 30, 2024 | 2 years ago |
| SMA: Bullish | Oct 29, 2024 | 2 years ago |
| SMA: Bearish | Oct 24, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 11, 2024 | 2 years ago |
| SMA: Bullish | Sep 26, 2024 | 2 years ago |
| RSI: Oversold | Aug 27, 2024 | 2 years ago |
| RSI: Oversold | Aug 21, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 14, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 26, 2024 | 2 years ago |
| RSI: Oversold | Jul 26, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 3, 2024 | 2 years ago |
| MACD: Sell Signal | May 31, 2024 | 2 years ago |
| RSI: Overbought | May 20, 2024 | 2 years ago |
| RSI: Overbought | May 16, 2024 | 2 years ago |
Key statistics
- Market cap
- 2.52M
- Enterprise value
- 3.08M
- Trailing P/E
- 0.00
- Forward P/E
- -0.63
- PEG ratio
- 0.00
- Price / sales
- 0.19
- Price / book
- 2.37
- EPS (TTM)
- -74.61
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -77.48%
- Revenue (TTM)
- 13.06M
- Revenue growth
- -25.20%
- Free cash flow
- 295.75K
- Total cash
- 776.00K
- Total debt
- 1.26M
- Return on equity
- -263.83%
- Shares outstanding
- 4.89M
- Short % of float
- 1.50%
- 50-day average
- 0.6314
- 200-day average
- 1.85
Analyst view
Consensus: none
Price target (mean) 3.73 +153.4% upside
Now 1.47
- Target (low)
- 0.85
- Target (mean)
- 3.73
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.24.
Financials — quick view
NBY Revenue — quarterly -521.00K
NBY Net income — quarterly -26.60M
NBY EPS — quarterly -7.70
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | main | Buy | Buy |
| Aug 11, 2023 | Ladenburg Thalmann | main | Buy | Buy |
About NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- novabay.com
News
- NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19%
- NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on NBY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FREIMAN PAUL EDWARD | Director | Conversion of Exercise of derivative security | May 10, 2023 | 1,783 |
| GARLIKOV JULIE | Director | Conversion of Exercise of derivative security | May 10, 2023 | 858 |
| SIT SWAN | Director | Conversion of Exercise of derivative security | May 10, 2023 | 1,716 |
| WU MIJIA | Director | Conversion of Exercise of derivative security | May 10, 2023 | 1,716 |
| ZHENG JEFF YENYOU | Director | Conversion of Exercise of derivative security | May 10, 2023 | 1,716 |
| ZHENG YONGXIANG | Director | Conversion of Exercise of derivative security | May 10, 2023 | 858 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| C2c Wealth Management, LLC | 0.88% | 42,948 | 22.19K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.54% | 26,337 | 13.61K | Sep 29, 2024 |
| UBS Group AG | 0.43% | 21,062 | 10.88K | Sep 29, 2024 |
| Virtu Financial LLC | 0.40% | 19,590 | 10.12K | Sep 29, 2024 |
| Warberg Asset Management LLC | 0.20% | 10,000 | 5.17K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.11% | 5,481 | 2.83K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.53% | 25,850 | 13.36K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.15% | 7,349 | 3.80K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.01% | 392 | 202 | Sep 29, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 31 | 16 | Sep 29, 2024 |